Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Choosing drugs for UK COVID-19 treatment trials

Chinnery, Patrick F., Bonnet, Marion ORCID:, Cave, Alison, Hofer, Matthias P., Lamb, Alastair, McConkey, Glenn A., Medcalf, Nicholas, Smith, Stephen P., Tsakok, Teresa, Watson, Robert, Webster, Steve and You, Tao 2021. Choosing drugs for UK COVID-19 treatment trials. Nature Reviews Drug Discovery 10.1038/d41573-021-00203-7

[thumbnail of NRDD Chinnery edited+PFC.pdf]
PDF - Accepted Post-Print Version
Download (276kB) | Preview
[thumbnail of NRD Chinnery Supplementary information.pdf]
PDF - Supplemental Material
Download (327kB) | Preview


In 2020, the UK government funded a portfolio of platform trials to develop new treatments for COVID-19. A key feature was the independent prioritization of candidate drugs with central coordination to prevent duplication, accelerating recruitment to deliver definitive trial results. A similar approach could be used for non-communicable diseases where treatment advances have been limited.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Nature Research
ISSN: 1474-1776
Date of First Compliant Deposit: 23 February 2022
Last Modified: 06 Dec 2023 18:07

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics